Since its inception in 1976, Cancer Immunology, Immunotherapy (CII) has reported significant advances in the field of tumor immunology. The journal serves as a forum for new concepts and advances in basic, translational, and clinical cancer immunology and immunotherapy. CII is keen to publish broad-ranging ideas and reviews, results which extend or challenge established paradigms, as well as negative studies which fail to reproduce experiments that support current paradigms, and papers that do succeed in reproducing others’ results in different contexts. Cll is especially interested in papers describing clinical trial designs and outcome regardless of whether they met their designated endpoints or not, and particularly those shedding light on immunological mechanisms.

CII is affiliated with the Association for Cancer Immunotherapy (CIMT), Canadian Cancer Immunotherapy Consortium (CCIC), The Japanese Association for Cancer Immunology (JACI), Network Italiano per la Bioterapia dei Tumori (NIBIT), and Sociedad Española de Inmunologia-Grupo Española de InmunoTerapia (SEI-GEIT).

CIMT: http://www.cimt.eu/home

CCIC: http://www.immunotherapycancer.ca/

JACI: http://www.jaci.jp/eng/index.html

NIBIT: http://www.nibit.org/index.php

SEI-GEIT: http://www.inmunologia.org/grupos/home.php?UpOm5=M&Upfqym5uom=GK

CITIM: http://www.canceritim.org 94% of authors who answered a survey reported that they would definitely publish or probably publish in the journal again

Journal information

Editor-in-Chief
  • Haidong Dong
Publishing model
Hybrid. Open Access options available

Journal metrics

4.9 (2018)
Impact factor
4.643 (2018)
Five year impact factor
28 days
Submission to first decision
196 days
Submission to acceptance
335,552 (2018)
Downloads

Latest articles

View all volumes & issues

Journal updates

View all updates

Societies, partners and affiliations

For authors

Submission guidelines Ethics & disclosures Contact the journal Submit manuscript

Subscribe

$199.00
Note this is only the net price. Taxes will be calculated during checkout.
  • Immediate online access
  • Full Journal access includes all articles
  • Downloadable in PDF
  • Subscription expires 12/31/2020

Advertisement

About this journal

Electronic ISSN
1432-0851
Print ISSN
0340-7004
Abstracted and indexed in
  1. AGRICOLA
  2. BIOSIS
  3. Biological Abstracts
  4. Chemical Abstracts Service (CAS)
  5. Current Contents/ Life Sciences
  6. EBSCO Academic Search
  7. EBSCO Biomedical Reference Collection
  8. EBSCO Discovery Service
  9. EBSCO STM Source
  10. EMBASE
  11. Elsevier Biobase
  12. Gale
  13. Gale Academic OneFile
  14. Gale InfoTrac
  15. Google Scholar
  16. Institute of Scientific and Technical Information of China
  17. Japanese Science and Technology Agency (JST)
  18. Journal Citation Reports/Science Edition
  19. Medline
  20. Naver
  21. OCLC WorldCat Discovery Service
  22. Pathway Studio
  23. ProQuest Biological Science Database
  24. ProQuest Central
  25. ProQuest Health & Medical Collection
  26. ProQuest Health Research Premium Collection
  27. ProQuest Immunology Abstracts
  28. ProQuest Medical Database
  29. ProQuest Natural Science Collection
  30. ProQuest Pharma Collection
  31. ProQuest Public Health Database
  32. ProQuest SciTech Premium Collection
  33. ProQuest-ExLibris Primo
  34. ProQuest-ExLibris Summon
  35. Reaxys
  36. SCImago
  37. SCOPUS
  38. Science Citation Index
  39. Science Citation Index Expanded (SciSearch)
  40. Semantic Scholar
Copyright information

Rights and permissions

Springer Nature policies

© Springer-Verlag GmbH Germany, part of Springer Nature